MMP9 and neoplasm: Here, tumours homozygous for the wild-type alleles of MMP9 rs2236416 and rs2274755 showed a median PFS of 9.48 months, and carrying at least one variant allele led to a reduced median PFS of 6 and 6.62 months, respectively (p = 0.022, p = 0.043, respectively).